ABVC BIOPHARMA, INC. Quarterly Nonoperating Income (Expense) in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Abvc Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2011 to Q2 2024.
  • Abvc Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$407K, a 925% decline year-over-year.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2023 was -$2.44M, a 509% decline from 2022.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$400K, a 181% decline from 2021.
  • Abvc Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was $495K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$407K -$367K -925% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$537K -$546K -6093% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q2 2023 -$39.7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $8.95K +$18.4K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2022 $486K -$9.41K -$9.48K -13354% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $495K $563K +$768K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 -$273K $8.64K +$895K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$1.17M -$77K +$962K +92.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$2.13M $71.00 +$179K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.31M -$205K -$186K -964% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.12M -$886K -$721K -435% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.4M -$1.04M -$872K -524% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$530K -$178K +$21.8K +10.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$552K -$19.3K +$2.84M +99.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$3.4M -$166K +$195K +54% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$3.59M -$166K +$122K +42.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$3.71M -$200K -$66.6K -49.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$3.65M -$2.86M -$2.83M -9973% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 -$811K -$360K -$333K -1211% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$478K -$288K -$260K -916% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$218K -$134K -$115K -604% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 -$103K -$28.4K -$28.5K Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 -$74.8K -$27.5K -$20.9K -315% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$54K -$28.4K -$25.1K -760% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$28.9K -$19K -$19.1K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$9.81K $49.00* -$143 Oct 1, 2016 Dec 31, 2016 10-KT 2018-04-13
Q3 2016 -$9.67K -$6.61K Jul 1, 2016 Sep 30, 2016 10-KT 2018-04-13
Q2 2016 -$3.3K -$3.3K Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-19
Q1 2016 $52.00* +$52.00 Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-19
Q4 2015 $192 +$192 Oct 1, 2015 Dec 31, 2015 10-Q/A 2018-03-19
Q2 2015 $0 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $0 $0 Jan 1, 2015 Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 $0 $0 Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-23
Q2 2014 $0 $0 +$16.5K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$16.5K $0 +$16.2K Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-05
Q4 2013 -$32.7K $0 +$16.4K Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 -$49.1K $0 +$14.9K Jul 1, 2013 Sep 30, 2013 10-K 2015-04-16
Q2 2013 -$64K -$16.5K -$3.04K -22.5% Apr 1, 2013 Jun 30, 2013 10-Q 2015-04-17
Q1 2013 -$61K -$16.2K -$3.9K -31.7% Jan 1, 2013 Mar 31, 2013 10-Q 2015-04-17
Q4 2012 -$57.1K -$16.4K -$198K -109% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q3 2012 $141K -$14.9K Jul 1, 2012 Sep 30, 2012 10-K 2015-04-16
Q2 2012 -$13.5K Apr 1, 2012 Jun 30, 2012 10-Q 2015-04-16
Q1 2012 -$12.3K Jan 1, 2012 Mar 31, 2012 10-Q 2015-04-16
Q4 2011 $182K Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.